Neonatal Sepsis: A Major Global Public Health Challenge
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Neonatal mortality is increasingly recognized as an important global public health challenge that must be addressed if we are to reduce child health disparities between rich and poor countries. Most of the estimated 4 million neonatal deaths per year occur in low and middle income countries.1 Three conditions: infection, birth asphyxia, and consequences of premature birth/low birth weight, are responsible for majority of these deaths. More than one-third are estimated to be due to severe infections, and a quarter are due to the clinical syndrome of neonatal sepsis/pneumonia. Case fatality rates for neonatal infections remain high among both hospitalized newborns and those in the community.1,2 In general, the identification and treatment of newborns with infection is unsatisfactory in many developing country settings. Because sick newborns present with nonspecific signs and symptoms, a clinical diagnosis of neonatal sepsis is difficult in even the most sophisticated settings. Many factors contribute to the high mortality due to infections, including under-recognition of illness, delay in care seeking at the household level, and lack of access to both appropriately trained health workers and to high quality services to manage sepsis. Even if quality services are available, the cost of treatment is beyond the reach of many families. It is particularly poignant that many neonatal deaths occur in the community, without the newborn ever having contact with the appropriate health services. At the turn of this new century, leaders throughout the world committed to working together to meet Eight Millennium Development Goals related to poverty reduction, expanded educational opportunities, gender equality, environmental sustainability, and improved health. Without addressing the causes of neonatal mortality and developing improved strategies for prevention, diagnosis and treatment, it will be impossible to meet Millennium Development Goal 4—to reduce child mortality by two-thirds between 1990 and 2015. Over the past several years, attempts have been made to raise awareness of the contribution of neonatal problems to overall infant mortality3,4 and to promote strategies to reduce mortality at the country level. Sixteen evidence-based cost-effective interventions have been identified to reduce neonatal mortality, during the preconception, antenatal, intrapartum and postnatal periods.5 Included among these is community-based case management of pneumonia. The evidence for effectiveness of community-based interventions for management of neonatal sepsis is less widely accepted.6,7 The purpose of this supplement is to evaluate available evidence on the burden of disease, etiology, antimicrobial resistance, and potential options for management of neonatal sepsis at the community level. The first 3 papers in this supplement resulted from a comprehensive review of the literature on neonatal sepsis commissioned by the Department of Child and Adolescent Health and Development, World Health Organization (WHO). Thaver and Zaidi8 report the findings from a review of community-based studies from developing countries to estimate rates of infections and infection-specific mortality. It is clear from this review that data from developing countries are limited in both quality and quantity. Zaidi et al9 review information about pathogens associated with neonatal sepsis in developing countries. Community-based data are almost completely lacking for the early neonatal period (ie, newborns in the first week of life). Most published data are from hospitals where Klebsiella species, E. coli, and Staphylococcus aureus are the most common causes of infection. Antimicrobial resistance patterns of neonatal pathogens are reported in another paper by Thaver et al10 These authors cite concerns about the emerging resistance of Klebsiella and E. coli to commonly used antibiotics. Although community-based data were scarce, lower antimicrobial resistance levels in the community are encouraging. Bhutta et al11 reviewed case management approaches for neonatal sepsis in the community settings of low resource countries. Despite limitations, these approaches hold promise for reducing neonatal mortality in such settings. In 2 papers, Darmstadt et al12,13 describe available data on use of oral and injectable antibiotics for the management of neonatal sepsis. They present advantages and disadvantages of various antibiotics and discuss some potential choices for simplified antibiotic regimens for the management of neonatal sepsis. Finally, Bahl et al14 using the Child and Nutrition Research Initiative (CHNRI) process for identifying priority areas for neonatal sepsis, report that management of neonatal infections in community settings is identified as a priority. Of note however, most top ranked priorities are related to health systems and policy research, perhaps due to limited progress in reducing neonatal mortality. It is no longer possible to overlook the im
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Infections are the commonest cause of death in infants less than four weeks old (neonates) [1-3].”
From A three year descriptive study of early onset neonatal sepsis in a refugee population on the Thailand Myanmar border (2013) · cites this paper as [3]
Citations
Cites
Evidence-based, cost-effective interventions: How many newborn babies can we save?
Darmstadt, G. L., Bhutta, Z. A., Cousens, S., Adam, T., Walker, N., & de Bernis, L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71088-6 · Cited by 1,541
Bang, A. T., Bang, R. A., Baitule, S. B., Reddy, M. H., & Deshmukh, M. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03046-9 · Cited by 842
Hospital-acquired neonatal infections in developing countries
Zaidi, A. K., Huskins, W. C., Thaver, D., Bhutta, Z. A., Abbas, Z., & Goldmann, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71881-x · Cited by 830
Baqui, A. H., El-Arifeen, S., Darmstadt, G. L., Ahmed, S., Williams, E. K., Seraji, H. R., Mannan, I., Rahman, S. M., Shah, R., Saha, S. K., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60835-1 · Cited by 588
Pathogens Associated With Sepsis in Newborns and Young Infants in Developing Countries
Zaidi, A. K. M., Thaver, D., Ali, S. A., & Khan, T. A. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181958769 · Cited by 385
Neonatal survival: a call for action
Martines, J., Paul, V. K., Bhutta, Z. A., Koblinsky, M., Soucat, A., Walker, N., Bahl, R., Fogstad, H., & Costello, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71882-1 · Cited by 314
Systematic scaling up of neonatal care in countries
Knippenberg, R., Lawn, J. E., Darmstadt, G. L., Begkoyian, G., Fogstad, H., Walelign, N., & Paul, V. K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71145-4 · Cited by 307
Thaver, D., & Zaidi, A. K. M. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181958755 · Cited by 292
Nontypeable Haemophilus influenzae as a Pathogen in Children
Murphy, T. F., Faden, H., Bakaletz, L. O., Kyd, J. M., Forsgren, A., Campos, J., Virji, M., & Pelton, S. I. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318184dba2 · Cited by 221
Antimicrobial Resistance Among Neonatal Pathogens in Developing Countries
Thaver, D., Ali, A., & Zaidi, A. K. M. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181958780 · Cited by 115
Cited by
Late-onset neonatal sepsis: recent developments
Dong, Y., & Speer, C. P. (2015) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/archdischild-2014-306213 · Cited by 520
Emerging Technologies for Molecular Diagnosis of Sepsis
Sinha, M., Jupe, J., Mack, H., Coleman, T. P., Lawrence, S. M., & Fraley, S. I. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00089-17 · Cited by 331
“contribute to the high mortality and morbidity rates associated with sepsis (34).”
BackgroundNeonatal Sepsis due to Coagulase-Negative Staphylococci
Marchant, E. A., Boyce, G. K., Sadarangani, M., & Lavoie, P. M. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/586076 · Cited by 215
“Neonatal sepsis is defined as infection in the first 28 days of life, or up to 4 weeks after the expected due date for preterm infants [1].”
Masino, A. J., Harris, M. C., Forsyth, D., Ostapenko, S., Srinivasan, L., Bonafide, C. P., Balamuth, F., Schmatz, M., & Grundmeier, R. W. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212665 · Cited by 183
Gebremedhin, D., Berhe, H., & Gebrekirstos, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154798 · Cited by 173
Metadata
- Authors
- Qazi, S. A., & Stoll, B. J.
- Affiliations
- World Health Organization (CH)
- Henrietta Egleston Hospital for Children (US)
- Corresponding author
- Qazi, Shamim A.
- Venue
- Pediatric Infectious Disease Journal
- Published
- 2009-01
- Volume
- 28
- Issue
- 1
- Pages
- S1-S2
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2057198514
- Cited by
- 139
- References
- 15
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 8 · 2021: 8 · 2020: 11 · 2019: 8 · 2018: 12 · 2017: 5 · 2016: 14 · 2015: 7 · 2014: 9 · 2013: 11 · 2012: 9
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Pediatric Infectious Disease Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- neonatal sepsis, neonatal mortality, community-based care, antimicrobial resistance, neonatal pneumonia, community-based case management, neonatal infection diagnosis, neonatal sepsis management, Millennium Development Goals, low- and middle-income countries, disease burden, health care access
- MeSH terms
- Humans, Infant, Newborn, Public Health, Global Health, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neonatal Sepsis: A Major Global Public Health Challenge. https://app.cochat.ai/papers/10.1097/inf.0b013e31819587a9
- The paper
- Qazi, S. A., & Stoll, B. J. (2009). Neonatal Sepsis: A Major Global Public Health Challenge. Pediatric Infectious Disease Journal. https://doi.org/10.1097/inf.0b013e31819587a9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.